This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08098/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08098/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08098/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n15http://linked.opendata.cz/resource/drugbank/drug/DB08098/identifier/chemspider/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n14http://linked.opendata.cz/resource/drugbank/drug/DB08098/identifier/chebi/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08098/identifier/pdb/

Statements

Subject Item
n2:DB08098
rdf:type
n3:Drug
n3:description
{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid is a solid. This compound belongs to the nitrofurans. These are compounds containing a furan ring which bears a nitro group. {[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid targets the protein aldose reductase.
n3:group
experimental
owl:sameAs
n6:DB08098 n7:DB08098
dcterms:title
[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid
adms:identifier
n10:2817424 n11:99444569 n12:DB08098 n13:LIT n14:43741 n15:2095728
n3:IUPAC-Name
n4:271B5DF7-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5DFD-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5DFC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5DF9-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5DFA-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5DFB-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5DF5-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5DF6-363D-11E5-9242-09173F13E4C5 n4:271B5DF3-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5DF4-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5E03-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5E04-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5DFE-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5DFF-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5E01-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5E00-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5E02-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5E09-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5E0B-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5E0C-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5E08-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5E07-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5E0A-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5DF8-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5E05-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5E06-363D-11E5-9242-09173F13E4C5